Pathology Laboratories, Inc. (PathLabs) is in the process of making updates to approximately eight (8) tests, which will be completed by Monday, August 21, 2023. These tests are performed by our reference laboratory partners; namely, Associated Regional University Pathologists (ARUP) of Salt Lake City, UT, National Medical Services (NMS) Labs of Horsham, PA, and Warde Medical Laboratory (Warde) of Ann Arbor, MI. Test updates relate to database changes made by these partners for the specified analytes.

Pathology Laboratories, Inc. (PathLabs) is in the process of making updates to approximately twenty (20) tests, which will be completed by Monday, July 17, 2023. These tests are performed by our reference laboratory partners; namely, Sonic Reference Laboratory (SRL) of Austin, TX, and American Esoteric Laboratories (AEL) of Memphis, TN. Both SRL and AEL are affiliates of Sonic Healthcare USA, Inc., as is PathLabs.

Full disclosure of the test updates is shown in the chart provided herein.

Pathology Laboratories, Inc. (PathLabs) is pleased to announce that we are bringing the STD (Sexually Transmitted Disease) testing for Chlamydia trachomatis (CT), Neisseria gonorrhea (NG), and Trichomonas vaginalis (TV) of urine specimens in-house effective December 27, 2022.

As a result of internalizing this testing, there are updates to our Urine STD tests; specifically for methodology, decreased analytic time, new collection devices, longer stability, and certain EMR code changes. In addition, Urine STD testing is no longer gender specific. However, an order code has been established for a male test for Trichomonas, using a swab collection device.

All testing updates are disclosed in the context of this publication and the chart provided below.

Pathology Laboratories, Inc. (PathLabs) is pleased to announce we will bring HPV, Pap, and STD (Sexually Transmitted Disease) Swab testing for Chlamydia trachomatis (CT), Neisseria gonorrhea (NG), and Trichomonas vaginalis (TV) in-house, effective Thursday, March 2, 2023.

As a result of internalizing this testing, PathLabs is in the process of updating our HPV, Pap, and STD Swab tests; specifically, to accommodate an expanded test menu, introduce a new methodology for molecular testing, convey decreased analytic times, present a new collection device for the Roche platform, and initiate EMR code changes.

As of June 12th, we are converting to a new Cytology/Histology Requisition (version 05/2023), shown at the end of this publication, to be used for ordering Cytology, Histology and Molecular testing. PathLabs’ sales team and supply department will be distributing the new requisition beginning next week.

All testing updates are disclosed in the context of this publication and provided in further detail in the charts below. All changes are marked in bright blue.

Pathology Laboratories, Inc. (PathLabs), in conjunction with our reference laboratory partners, is in the process of making updates to its test menu for various changes as fully described within the contents of this technical bulletin. Although some updates were effective in late April 2023, the majority are set for implementation on Monday, May 15, 2023, as disclosed in the chart provided herein.

Pathology Laboratories, Inc. (PathLabs) is in the process of making updates to our Test Directory based on changes being made by our reference laboratory partner, Clinical Pathology Laboratories (CPL), a Sonic Healthcare USA, Inc. affiliate of Austin, Texas.

Effective May 8, 2023, PathLabs is pleased to announce that CPL will change its analytic platform and method for Thyroglobulin Antibody (Anti-Tg) and Thyroid Peroxidase Antibody (Anti-TPO). The new methodology is electrochemiluminescence immunoassay (ECLIA).

As part of Pathology Laboratories, Inc.’s (PathLabs) continuous dedication to providing quality results and assure optimal cytology specimens, all Routine Non-Gynecologic fluids (e.g., urine for cytology and sputum) must be submitted in ThinPrep® CytoLyt® Solution. The ThinPrep® CytoLyt® Solution is a water-based, buffered cell wash solution designed to lyse red blood cells, prevent protein precipitation, dissolve mucus and preserve the morphology of the cellular material. When all Routine Non-Gynecologic fluids (e.g., urine for cytology and sputum) are placed in ThinPrep® CytoLyt® Solution, the specimen cellular material is properly preserved.

Pathology Laboratories, Inc. (PathLabs), a Sonic Healthcare Clinical Laboratory and division of Sonic Healthcare USA, Inc., is privileged to welcome Anastasia M. Canacci, M.D., as Medical Director. Dr. Canacci joins PathLabs with an extensive career in laboratory medicine.

Pathology Laboratories, Inc. (PathLabs) is in the process of making updates to the Reporting Titles and Result Code Descriptions of the STD (Sexually Transmitted Disease) Swab Testing for Chlamydia trachomatis (CT), Neisseria gonorrhea (NG), and Trichomonas vaginalis (TV). The updates are based on changes being made by our reference laboratory partner, Clinical Pathology Laboratories (CPL), a Sonic Healthcare USA, Inc. affiliate in Austin, Texas. These updates will be effective at PathLabs beginning Monday, January 23, 2023, as disclosed in the chart provided herein.

Pathology Laboratories, Inc. (PathLabs) is in the process of making updates to certain CPT Codes for 2023, and various Order Code Reporting Titles and Result Codes Descriptions to better correlate with specific CPT Code Descriptions, as published by the American Medical Association. These changes will be effective Tuesday, January 3, 2023, as disclosed in the chart provided herein.

Pathology Laboratories, Inc. (PathLabs) is in the process of making updates to TORCH tests based on changes being made by our reference laboratory partner, Clinical Pathology Laboratories (CPL), our Sonic Healthcare USA, Inc. affiliate of Austin, Texas.

Pathology Laboratories, Inc. (PathLabs) is in the process of making updates to Pap test Order Codes based on changes being made by our reference laboratory partner, Clinical Pathology Laboratories (CPL), a Sonic Healthcare USA, Inc. affiliate of Austin, Texas.

Specifically, CPL’s changes reflect adoption of a consistent methodology for Pap tests that will provide computer-guided screening for all liquid-based Pap tests.

Further details are provided below and within the context of this publication.

Pathology Laboratories, Inc. (PathLabs) is in the process of making updates to STD (Sexually Transmitted Disease) testing for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) related to SurePath™, ThinPrep®, and urine specimens based on changes being made by our reference laboratory partner, Clinical Pathology Laboratories (CPL), a Sonic Healthcare USA, Inc. affiliate of Austin, Texas.

Pathology Laboratories, Inc. (PathLabs) is announcing an update to six (6) Order Codes based on changes being made by our reference laboratory partner, Clinical Pathology Laboratories, a Sonic Healthcare USA, Inc. affiliate of Austin, Texas.

Specifically, the changes reflect adoption of a consistent methodology for these particular tests, which is Capillary Electrophoresis, effective Monday, September 19, 2022. Further details are provided below and within the context of this publication.

Pathology Laboratories, Inc. (PathLabs) is announcing a new test offering for Monkeypox Virus PCR, that will be performed at our sister laboratory, Sonic Reference Laboratory (SRL), effective August 24, 2022. This test can be performed on clinical specimens collected during the acute/symptomatic phase of illness from patients suspected of Monkeypox. Further details are disclosed in this document.

Pathology Laboratories, Inc. (PathLabs) is in the process of making updates to Random Urine Microalbumin testing, which will be effective Monday, August 22, 2022, as disclosed in the chart provided herein.

Pathology Laboratories, Inc. (PathLabs) is in the process of making updates to Fluid Testing and 24 Hour Urine Testing, which will be effective Monday, August 8, 2022, as disclosed in the chart provided herein.

Pathology Laboratories, Inc. (PathLabs) is in the process of making updates to the Covid Antibody Testing that we offer. Beginning Monday, August 8th, an additional Antibody test will be offered, SARS CORONAVIRUS 2 IGG ANTIBODY. For your convenience, all Covid Antibody Tests offered are disclosed in the chart provided herein. This publication supersedes our Covid Antibody Test Update effective June 27, 2022.

Pathology Laboratories, Inc. (PathLabs) is in the process of making updates to its database affecting the reference range for the Anion Gap and the offering of the Troponin test. The changes will be effective Monday, August 1, 2022, as more fully described in the chart provided herein.

Pathology Laboratories, Inc. (PathLabs) is in the process of making updates to approximately 75 tests, which will be completed by Monday, July 25, 2022, as disclosed in the chart provided herein. 

Covid Antibody Test Updates

Effective June 27, 2022

In response to recommendations from the National Kidney Foundation and American Society of Nephrology (NKF-ASN) Task Force on estimated glomerular filtration rate (eGFR), effective 06/06/2022, Pathology Laboratories will adopt the single CKD-EPI Refit equation to replace the separately reported eGFR ---- Black and eGFR non-Black calculations for all serum creatinine measures.

Effective June 1, 2022, Pathology Laboratories (PathLabs) will have new contact information as disclosed in the chart provided herein.

Test Updates Effective May 31, 2022

Test Updates Effective May 23, 2022

Test Updates Effective May 9, 2022 

Test Updates Effective April 4, 2022 

Test Updates Effective March 28, 2022

Health Resources and Services Administration (HRSA) COVID-19 Uninsured Program

Test Updates Effective March 21, 2022

Test Updates Effective March 14, 2022 

Ammonia Test Update/New Specimen Requirements

Covid Rt-PCR Test Update/New Covid Requisition and Patient History Form

SARS-CoV-2 Omicron Variant of Concern

Testosterone Update

Gastrointestinal Pathogens Panel Update

Effective September 1, 2021, the specimen requirement has changed for Iron Binding Capacity and Transferrin. 

Effective August 30, 2021, Anti-Nuclear Antibodies testing will be performed at Clinical Pathology Laboratories (CPL).  Please refer to the attached pdf for database updates and changes.

Gastrointestinal Pathogens PCR testing update

Immunoassay for the semi-quantitative determination for
antibodies to the SARS-CoV-2 Spike protein

Effective Monday, April 12, 2021, ProMedica Pathology Laboratories (PPL) will offer an additional serological test for SARS-CoV-2 Antibodies, specific to the spike (S) protein.

Bioavailable Testosterone testing update

Urine trichomonas testing update

View the Sonic Healthcare USA COVID-19 Testing Program 

Effective Monday, November 9, 2020, ProMedica Pathology Laboratories (PPL) will offer the Roche cobas® SARS-CoV-2 & Influenza A/B multiplex assay.

ProMedica Pathology Laboratories has updated information for SARS-Cov-2/COVID-19 testing.

Effective August 10, 2020, there is a change to the low blood glucose critical value.

On June 4, 2020, the U.S Department of Health and Human Services (HHS) published new requirements for patient data collection and reporting for COVID-19 test results.

Effective July 27, 2020, there are changes to the reference ranges for certain CBC parameters.

Serologic testing will report ONLY the IgG antibodies to SARS-COV-2/COVID-19.

Sonic Healthcare USA issues a media statement on testing capacity for COVID-19.

Please click on the link for The American Clinical Laboratory Association's update on COVID-19 testing capacity.

Please follow the link for specific test information.

ProMedica Pathology Laboratories (ProMedica PathLabs) will be making updates and modifications to our database, as more fully described in the disclosure attached.

Please follow the link for an important update about the ABBOTT serologic testing for SARS-Cov-2/COVID19.

Please follow the link for an important update about the EUROIIMUN serologic testing for SARS-Cov-2/COVID19.

COVID-19 Client Communication: SARS-COV-2 (COVID-19) by RT-PCR.

Please follow the link for important information about the availability of testing for SARS-Cov-2/COVID19 serologic testing for IgG and IgA.

Please follow the link for an update on COVID-19 prices and CPT codes for RT-PCR and serologic testing.

Please follow the link for an update on COVID-19 prices and CPT codes.

Sonic Healthcare USA is closely monitoring the situation regarding the 2019 Novel Coronavirus (COVID-19). We are dedicated to promoting a healthy and safe environment for our patients and employees.

Sonic Healthcare USA is closely monitoring the situation regarding the 2019 Novel Coronavirus (COVID-19). We are dedicated to promoting a healthy and safe environment for our patients and employees.

Sonic Healthcare USA has issued the following update containing important information about test availability, capacity, turn-around time, and pricing.

ProMedica Pathology Laboratories is pleased to announce that testing for SARS-Cov-2/COVID19 is available effective immediately. 

Simplification of insurance selections in Atlas effective November 20, 2019.

H. pylori IgA, H. pylori IgG and H. pylori IgM tests will be discontinued effective November 4, 2019.

Effective July 1, 2019, a new billing system has been added.

Updates to EMR files are required for the General Microbiology migration occurring on August 26, 2019.

Microbiology testing migrates to ProMedica Laboratories (ProMedica PathLabs) effective August 26, 2019.

Effective August 26, 2019, new collection devices will be used for Blood Cultures.

New collection devices are available for collection of specimens for culture.

Effective July 1, 2019 Molecular Testing is transitioning to ProMedica Laboratories (ProMedica PathLabs).

Effective Monday, June 24, 2019, Pathology Laboratories, Inc. (PathLabs) will be transitioning Urine and Urine Culture testing to ProMedica Laboratories (ProMedica PathLabs).

Effective June 24, 2019 Urinalysis and Urine Culture testing will transition to ProMedica Laboratories (ProMedica PathLabs).

The ordering code for Protein/Creatinine Ratio, 24 Hr Urine has changed to 58100.

Effective May 13, 2019 there are several changes to order/result codes for Herpes testing.

Additional changes not included in the previous Urine Chemistry communications are included in this document.

This document provides updates to the information provided in the April 4, 2019 communication.

Urine Chemistry testing is migrating to ProMedica Laboratories (ProMedica PathLabs).

Effective April 1, 2019 Clinical Chemistry testing is migrating to ProMedica Laboratories (ProMedica PathLabs).

Order codes for several tests have been retired.

Effective February 25, 2019 Ova and Parasite testing is to be ordered with code 39216.

Effective January 14, 2019 Post-vasectomy Semen Analysis is being discontinued.

High Sensitivity Troponin T is now available.